Chunli Medical (688236): Better hip coverage is expected, knee replacement is expected
Chunli Healthcare (688236): Performance growth is affected by policies, optimistic about subsequent recovery
Guoxin Securities released a research report on April 10 stating that it gave Chunli Healthcare (688236.SH) a purchase rating. The main reasons for the rating include: 1) the performance was partially affected by collection, and net profit fell 9.7% in 20
Chunli Healthcare (688236): Cash flow improved significantly year on year, overseas revenue increased by 82% year on year
Chunli Medical (688236) Annual Report Review: Short-term performance is affected by collection, and recovery is expected to accelerate in 24 years
Chunli Medical (688236) 2023 Report Review: Collection affects 23-year performance with high overseas business growth
Chunli Medical (688236): The impact of collection is gradually clear, and overseas business expansion is accelerating
Chunli Healthcare (688236): Significant improvement in cash flow, outstanding overseas performance
Chunli Healthcare (688236): Significant improvement in cash flow in 23 years, impressive overseas performance
Chunli Medical (688236): The impact of inventory returns and exchanges is gradually weakening, and international business is expanding rapidly
Chunli Medical (688236): After short-term pressure on performance, the collection era is expected to usher in restorative growth
Chunli Medical (688236): Performance is in line with expectations, joint contract renewal or benefits
Chunli Medical (688236) Company News Research Report: The impact of collection is gradually being cleared, and performance is expected to reach an inflection point
Chunli Medical (688236): The impact of gathering leading domestic sheep in the joint field is gradually becoming clear
Chunli Medical (688236): The impact of collection is gradually being revealed, focusing on inflection points in the company's performance
Chunli Medical (688236) First Coverage Report: Collecting Disruptions and Removing Diversified Layouts to Welcome Next Spring
Chunli Medical (688236): Collecting Disturbances and Removing Diversified Layouts to Welcome Next Spring
Chunli Medical (688236): Revenue increased by 33% in the third quarter alone and continued to consolidate its leading position in joint
Chunli Medical (688236): Excluding high net profit growth, optimistic about continued recovery next year
Chunli Medical (688236) Company Incident Review Report: The impact of mining is gradually digested and market expansion capacity is steadily improving
No Data